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Abstract 
Cholesterol is a major component of membranes, reducing their fluidity at higher 
concentrations. The UV Raman vibrational mode of the carbon-carbon double bond in 
cholesterol occurs at 1675 cm-1 is strongly resonance enhanced in deep ultraviolet 
resonance Raman (dUVRR) spectra of natural and model membranes at an excitation 
wavelength of 197 nm. DUVRR is a vibrational spectroscopic technique that is used to 
gather information on protein secondary structure and in this work is extended to study 
systems in the presence of the membrane component cholesterol and the cholesterol 
analog 5α-cholestan-3ß-o, which lacks the carbon-carbon double bond.  
DUVRR studies of melittin indicated that little loss of helical structure occurred with 
increasing temperature as was suggested by circular dichroism (CD), another structurally 
sensitive spectroscopic technique. A cholesterol analog was introduced to decrease the 
fluidity of membrane in a similar manner to cholesterol, while minimizing spectroscopic 
interference from the resonant enhanced carbon-carbon double bond vibration. With the 
introduction of the cholesterol analog a loss in helical structure of the melittin was seen in 
both the dUVRR and CD. 
Lipoproteins transport cholesterol through the blood stream. Studies have shown that an 
individual’s lipoprotein levels are correlated with their risk of cardiovascular disease. The 
strongly resonantly enhanced dUVRR feature of the carbon-carbon double bond was used 
to quantify cholesterol in lipoprotein particles isolated from whole blood. Like 
cholesterol, unsaturated lipids give rise to a strongly enhanced vibrational mode in 
dUVRR spectra, which is slightly downshifted from that of cholesterol. The vibrational 
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mode of unsaturated lipids occurs in the region of 1655-1661 cm-1, depending on the type 
of lipid. The feature arising from the unsaturated lipids was found to be sufficiently 
resolved from cholesterol’s feature to allow quantitation of cholesterol in model 
membranes and lipoproteins. 
Isolation and characterization of lipoproteins is an emerging field as studies show that 
cardiovascular disease risk is a complex function of not just cholesterol and lipoprotein 
levels but also their size distribution. Spectroscopic methods are readily coupled with 
chromatographic techniques. Size exclusion chromatography (SEC) was employed to 
separate lipoproteins based on their size from a series of blood serum samples. Each 
volume fraction was spectroscopically characterized via dUVRR spectroscopy producing 
a two-way data matrix for each sample, which could then be analyzed using higher order 
multivariate methods. Parallel factor (PARAFAC) analysis and multivariate curve 
resolution-alternating least squares (MCR-ALS) were employed to resolve the underlying 
spectroscopic and chromatographic profiles. The resolved profiles were attributed to 
lipid/cholesterol, protein and buffer components.
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Introduction 
Deep Ultraviolet Resonance Raman (dUVRR) spectroscopy has traditionally been 
applied to secondary structure determination in aqueous proteins. Work with this 
technique in membrane systems is a relatively new endeavor1-4. Membrane proteins are a 
vital part of our cellular biology but are not as well studied as their aqueous soluble 
counterparts due to the experimental challenges of working with lipids for traditional 
techniques like nuclear magnetic resonance (NMR) or X-ray crystallography. Saturated 
lipids are nearly invisible in dUVRR spectra of lipid-solubilized proteins, leaving only 
the structurally sensitive modes from peptide bond of the protein itself resonantly 
enhanced. Thus, dUVRR spectra can be collected with very little sample preparation and 
with no required modifications to the membrane protein. Additionally, the amide I 
vibrational mode is a built-in marker for lipid solvation3-4. 
One of the greatest health risks we currently face is heart disease5. Heart disease has been 
linked to blood cholesterol levels and its carrier molecules, lipoproteins6-12. Current 
clinical methods for the analysis of blood cholesterol levels do not measure cholesterol or 
the lipoproteins directly but instead rely on enzymatic reactions, associated protein 
quantitation, and calculations. These indirect methods can lead to inaccurate results 
which could imply an improper course of treatment. The vibrational mode arising from 
the carbon-carbon double bond found in biological molecules like fatty acids, unsaturated 
lipids, and cholesterol is resonant enhanced in dUVRR spectra. The ability to quantitate 
cholesterol while also monitoring the protein content associated with lipoprotein particles 
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makes dUVRR a unique tool in this field. Coupled with a separation technique like size 
exclusion chromatography (SEC) dUVRR can play a vital role in a new direct approach 
to blood cholesterol analysis. 
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Chapter 1 
Eagleburger, M.K.; Cooley, J.W.; JiJi, R.D., Effects of Fluidity on the Ensemble 
Structure of a Membrane Embedded α-helical Peptide. Biopolymers 2014, 101(8), 895-
902.  
Introduction 	
Membrane proteins are often termed the gatekeepers of the cell and are involved in 
cellular trafficking, environmental sensing, and energy metabolism. Membrane proteins 
are associated with a number of different diseases and thus make up over 50% of current 
drug targets13-14. While the role of membrane proteins in cellular processes is quite 
important, less is known about membrane proteins than their soluble counterparts15-16. It 
is thought that 20-30% of the genome codes for membrane proteins17-18. However, there 
are currently only 387 unique 3D structures of membrane proteins, less than 1% of all 
known 3D protein structures 19.  
Traditional techniques for soluble protein structure determination such as X-ray 
crystallography and solution-state nuclear magnetic resonance (NMR) 20 are not 
amenable to structural analysis in intact bilayers. This means that analysis of membrane 
proteins and their dynamics in their native environments has not traditionally been 
feasible. As a result, infrared (IR) and circular dichroism (CD) spectroscopies have been 
relied upon for structure determination21-22. These techniques report on the ensemble 
secondary structure content of a protein.  
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Deep-ultraviolet resonance Raman spectroscopy (dUVRR) is an emerging vibrational 
method that has been used to estimate the secondary structural content of soluble 
proteins.  As the dUVRR spectra, like IR, represent the sum of all of a protein’s 
secondary structural elements, the spectra can therefore be deconvoluted into the pure 
secondary structure content components23-27. Only recently has dUVRR spectroscopy 
been applied to the field of membrane proteins3-4, 28-30 revealing that selective excitation 
of the amide backbone results in a strong protein signal with little interference from the 
lipid and buffer components. Furthermore, the dUVRR spectra of lipid desolvated 
proteins have an enhanced amide I mode3-4. Yet, despite its promise as a complimentary 
tool for the study of membrane proteins, further work is needed to determine the effects 
of the membrane environment on the dUVRR spectra of proteins. 
Melittin is a small 26-residue amphiphillic protein, and is the main hemolytic component 
of honeybee venom. Melittin is readily soluble in water where it adopts a disordered 
structure31-32, but in the presence of a suitable membrane environment melittin will 
spontaneously insert into the membrane and adopt an α-helical conformation33-35.  Once 
associated with a membrane system the structure and function of melittin are dependent 
upon the type and phase of the lipid membrane36-39. Cholesterol is also known to 
influence the ability of melittin to bind to lipid membranes and induce cell lysis40-41.  A 
great deal of the melittin literature is devoted to studying this lytic ability, with the focus 
on the changes effected by melittin on the membrane systems. Studies aimed at observing 
the secondary structure of melittin in different membrane conditions or with cholesterol 
are few36, 40, 42. Anderson et. al. showed a small reduction in the α-helical character of 
melittin in bicelles and in cholesterol doped bicelles with an increase in temperature by 
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CD. Wessman et. al. studied the interaction of melittin with DOPC liposomes doped with 
cholesterol by CD and also saw a decrease in the α-helical content of melittin in the 
presence of cholesterol.     Here, we further elucidate the structure of melittin upon 
interaction with 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) liposomes with 
differing fluidities by CD and dUVRR spectroscopy, and reveal a unique sensitivity of 
dUVRR spectroscopy for resolving subtle structural fluctuations associated with 
changing membrane environment.  
Materials and Methods 	
Cholesterol, monosodium phosphate monohydrate, disodium phosphate heptahydrate, 
sodium chloride, and chloroform were purchased from Fisher Scientific (Pittsburgh, PA). 
5α-cholestan-3ß-ol and diphenylhexatriene (DPH) were purchased from Sigma-Aldrich 
(St. Louis, MO). 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) was purchased 
from Avanti Polar Lipids Incorporated (Alabaster, AL). Melittin was purchased from Pi 
Proteomics (Huntsville, AL).  
	Lipid Vesicle Preparation for Anisotropy Measurements 
DMPC was dissolved in a 65:35:8 mixture of chloroform, methanol, and water, 
respectively. DPH, cholesterol, and 5α-cholestan-3ß-ol were dissolved in chloroform. 
Cholesterol and 5α-cholestan-3ß-ol were added to the DMPC at 0, 10, and 25 molar 
percent. For anisotropy measurements DPH was also added to the solution. Each solution 
was then dried under a stream of argon until a thin film was formed on the bottom of the 
container. The mixture was then further dried in a vacuum desiccator for more than one 
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hour. The mixture was rehydrated in 10 mM phosphate buffer (pH 7.4), and sonicated in 
a heated water bath for one hour and extruded 21 times through an Avestin LiposoFast 
(Ottawa, ON) extruder with a 100 nm filter to form monodisperse liposome vesicles with 
a hydrodynamic radius of 31 nm. These vesicles were then diluted in phosphate buffer to 
give a final lipid/cholesterol/5α-cholestan-3ß-ol concentration of 50 µM and a final DPH 
concentration of 0.5 µM for anisotropy measurements. Melittin containing vesicles were 
prepared as above with Melittin being dissolved in water and added to the vesicle 
solution at a concentration of 2 molar percent. 
Measuring membrane fluidity with fluorescence anisotropy 
Fluorescence anisotropy (r) of DPH was measured with a Cary Eclipse fluorescence 
spectrometer with a manual polarizer. The following equations were used to determine 
r43:  
𝑟 = 𝐼$$ − 𝐺𝐼$'𝐼$$ + 2𝐺𝐼$' 						𝐺 = 𝐼'$𝐼'' 
IVV is the fluorescence intensity with the excitation and emission polarizers in the vertical 
position. IVH is the fluorescence intensity with the excitation polarizer in the vertical 
position, and the emission polarizer in the horizontal position. IHV and IHH are the 
fluorescence intensities with the excitation polarizer in the horizontal position, and the 
emission polarizer in the vertical, and horizontal positions, respectively. G is a correction 
factor for the sensitivity of the instrument to vertically and horizontally polarized light. 
The fluorescence anisotropy of the DMPC vesicles was observe at 37 °C. The 
temperature in the fluorescence spectrometer was controlled using a Neslab RTE-111 
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temperature control unit and samples were kept in a constant temperature water bath 
when not being measured.     
Deep Ultraviolet Resonance Raman (dUVRR) 
The dUVRR instrument setup has been described previously44. In short, the fourth 
harmonic of a tunable Ti:Sapphire Coherent laser (Santa Clara, CA) was focused on a 
flowing sample. The sample chamber contained two nitinol wires approximately 1 mm 
apart, between which the sample flowed. The sample chamber was purged with nitrogen 
gas to remove ambient oxygen. The samples were excited with 197 nm light with an 
average power of 0.5 mW to minimize the risk of sample degradation. Samples were kept 
at a constant temperature using a custom-made water-jacketed cell (Mid Rivers 
Glassblowing, St. Charles, MO) and a Fischer Scientific (Pittsburgh, PA) Isotemp 3016D 
circulating water bath. Melittin samples were made as above, 2 molar percent melittin in 
DMPC liposomes, with 20 mM phosphate buffer (pH 7.4, 5 mM NaCl) and without the 
addition of DPH. Melittin/DMPC liposomes were diluted to a final melittin concentration 
of 0.5 mg/mL. Sodium perchlorate (50mM) was added to the samples as an internal 
intensity standard. 
Circular Dichroism 
Circular dichroism measurements were taken on a Jasco (Easton, MD) J-710 
Spectrophotometer with a 1 mm path length cuvette. Samples were scanned from 250 nm 
to 190 nm with a data pitch of 0.1 nm, a band width of 1 nm, a scanning speed of 50 
nm/min, a response time of 4 seconds, and with 5 total accumulations. Temperatures for 
the CD spectra were controlled by a Julabo (Allentown, PA) AWC100 temperature 
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control unit. Samples were prepared in a similar manner as the above dUVRR samples. 
All spectra were buffer and DMPC corrected and converted to mean residue ellipticity 
(θMRE). Multiple trials were collected and only a single representative spectrum from each 
experiment is shown. Oriented CD (OCD) measurements were obtained using the Jasco 
J-710 Spectrophotometer fitted with an OCD attachment manufactured by Jasco. OCD 
samples were prepared as the above dUVRR samples, with a small volume being placed 
on a quartz plate. The plated sample was then dried in a desiccator containing an 80% 
zinc chloride solution. The plate was then placed in the OCD sample cell and rehydrated 
with 1 mL of water. OCD spectra were taken at six positions, averaged, and DMPC 
corrected.   
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Results 	
 
Figure 1-1: Fluorescence anisotropy of DPH in DMPC liposomes containing cholesterol 
(squares), 5α-cholestan-3β-ol (triangles), and 5α-cholestan-3β-ol plus two molar percent 
melittin (circles).  Error bars indicate the deviation of the fluorescence anisotropy 
between three experimental collections. 
 
The fluorescence anisotropy of DPH in DMPC membranes was measured to compare the 
effect of cholesterol, which is known to decrease membrane fluidity, with 5α-cholestan-
3β-ol, a cholesterol analog. The use of 5α-cholestan-3β-ol is necessitated by spectral 
interference from the double bond in cholesterol in both CD and dUVRR spectra. An 
increase in anisotropy with increasing concentration was observed for both cholesterol 
and 5α-cholestan-3β-ol  (Figure 1-1). An increase in anisotropy is correlated with a 
decrease in the fluidity of the DMPC bilayer. The addition of melittin to the DMPC 
liposomes with 5α-cholestan-3β-ol did not significantly change the DPH anisotropy. This 
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suggests that 5α-cholestan-3β-ol decreases membrane fluidity in a similar manner as 
cholesterol and that melittin itself does not alter the fluidity of the DMPC liposomes.  
Previous studies have shown that melittin adopts a disordered structure in an aqueous 
environment31-32, and α-helical structure in a membrane or membrane-mimicking 
environment33-35. The CD spectrum of melittin in an aqueous environment has a single 
minimum at 198 nm consistent with disordered structure (Figure 1-2)45-46. Introduction of 
DMPC liposomes induces folding of melittin47-48 and results in an α-helical CD spectrum 
with two minima at 209 nm and 222 nm, and a single maximum at 192 nm (Figure 1-2).  
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Figure 1-2: DUVRR (top) and CD (bottom) spectra of melittin in water (grey) and in 
DMPC liposomes (black). 
 
DUVRR spectra of proteins are dependent on their secondary structure composition. 
Recent studies have shown that dUVRR spectroscopy is amenable to structural studies of 
membrane-solubilized proteins3-4, 30, 49. There are four observable amide modes, the 
amide I, II, III and S modes. The amide I is a carbonyl stretching mode and is typically 
quite weak in a-helical and disordered conformations. Hydrogen bonding between the 
backbone carbonyl and the solvent greatly diminishes the intensity of the amide I band28, 
50-51. The amide II is a coupled N-H bending/C-H stretching mode. Although the position 
and intensity of the amide II mode is sensitive to secondary structure, the observed shifts 
are much smaller than those observed for the amide III band. The amide III mode is a Cα-
H bending/C-N stretching mode and is coupled with the amide S mode, a Cα-H 
bending/N-H bending mode, in disordered and b-sheet conformations 52. The amide S 
mode is not resonance enhanced in a-helical conformations24, 53. 
Similar to the CD spectra, the UVRR spectra indicate a major structural difference in 
melittin between the aqueous and membrane environments. The maximum of the amide 
III mode for aqueous melittin occurs at 1251 cm-1 and the amide S maximum occurs at 
1391 cm-1. The position and intensity of the amide III and S modes, as well as the amide 
II maximum at 1553 cm-1 and amide I maximum at 1665 cm-1 are consistent with 
disordered structure24, 54-55. For melittin in DMPC liposomes the amide III maximum 
shifts up to 1285 cm-1 and the intensity of the amide S mode decreases dramatically, both 
indications of folding into an α-helix25, 56. While the position of the amide I band (1652 
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cm-1) is consistent with a-helical structure, the intensity of the amide I maximum is much 
stronger than typically observed for globular α-helical proteins. The strong intensity of 
the amide I band indicates that the backbone of melittin is desolvated in the presence of 
DMPC bilayers consistent with previous dUVRR studies of lipid solvated proteins3-4.  
 
Figure 1-3: CD spectra of melittin in DMPC from 7°Cto 37°C. 
 
Fluorescence anisotropy of DPH in DMPC bilayers is approximately 0.35, 0.3 and 0.1 at 
7°C, 23°C, and 37°C, respectively, indicating that the DMPC bilayer is in the gel state at 
room temperature and below. CD spectra of melittin (Figure 1-3) show a slight increase 
in the intensity of the maximum in the 192-194 nm region and the minimum at 222 nm 
with increasing temperature up to 22°C, indicating a slight increase in helical content 
from 7° to 22°C. Above 22°C, the maximum and minimum at approximately 193 and 222 
nm decrease in intensity to a much larger extent, suggesting a significant loss of helical 
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content at physiological temperature (37°C). A red shift (192 nm to 193.5 nm) in the 
maxima around 193 nm and the minima around 208 nm can be seen from 7°C to 37°C. 
 
 
Figure 1-4: DUVRR temperature profile of melittin in DMPC liposomes. Spectra were 
collected from 7°C to 37°C in intervals of 5°C. 
 
To determine if melittin partially unfolds at physiological temperatures, dUVRR spectra 
were collected from 7°C to 37°C (Figure 1-4). The amide S mode (1370-1400 cm-1) is a 
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marker for non-helical structure in dUVRR spectra of proteins53, 57. In the dUVRR 
temperature profile of melittin, the amide S mode at 1383 cm-1 in all the spectra is very 
weak and does not change significantly. This indicates that melittin is adopting a highly 
helical structure in DMPC liposomes at all observed temperatures. However, an increase 
in the amide III intensity at 1240 cm-1 can be observed with increasing temperature in the 
spectra above 22°C. Given that there is little change in the amide S intensity, this 
indicates that the helical structure of the melittin remains intact58.  
 
Figure 1-5: Plot of dUVRR amide III intensity at 1240 cm-1 and CD intensity at 222 nm 
versus temperature of the dUVRR temperature profile (solid squares) and CD 
temperature profile of melittin (dashed circles).   
 
The tryptophan modes in the dUVRR spectra are weak and seen as shoulders on the 
amide I and amide II modes. The dUVRR data coupled to the CD data suggests that 
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melittin is not unfolding at higher temperatures but is sampling a greater range of 
dihedral angles, as the lipid environment changes from a gel to liquid state. The intensity 
of the amide III band at 1240 cm-1 increases concurrently with a decrease in the negative 
ellipticity at 222 nm (Figure 1-5). The position and intensity of the lowest frequency 
amide III band has been shown to be dependent on the ψ dihedral angle58-61. The 
appearance of a band at 1240 cm-1 is consistent with formation of a small amount of 310-
helical structure, possibly at the termini of the a-helix60. It has been suggested the 310-
helical structure is an intermediate between a-helical and disordered structure62. 
The temperature dependence of the CD and dUVRR suggest that in a gel like lipid 
environment the peptide adopts a more uniform helical structure.  Alternatively, 
cholesterol is known to decrease lipid fluidity as does 5α-cholestan-3β-ol (Figure 1-1). In 
order to study the effect of decreasing lipid fluidity on the structure of melittin at 
physiological temperature 5α-cholestan-3β-ol was added to DMPC liposomes at 10 and 
25 molar percent.  
The CD spectra of melittin with 5α-cholestan-3β-ol shows a slight increase in the maxima 
in the 192-194 nm region and a slight decrease in the minima at 208 nm and 222 nm 
between 0 and 10 molar percent 5α-cholestan-3β-ol (Figure 1-6). Between 10 and 25 
molar percent 5α-cholestan-3β-ol, a large decrease in intensity across the spectra can be 
observed, which may be interpreted as a loss of helical structure (Figure 1-6). The OCD 
spectra show an increase in the ratio of 214 nm intensity/228 nm intensity from 0.669 at 0 
molar percent 5α-cholestan-3β-ol to 0.784 at 10 molar percent 5α-cholestan-3β-ol. The 
ratio increases again to 0.834 between 10 and 25 molar percent 5α-cholestan-3β-ol. The 
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increase in the relative intensity of the 214 nm minimum suggests an increase in the tilt 
angle of the melittin helix with respect to the bilayer normal63-65. 
The CD spectra of melittin with increasing molar percentages of 5α-cholestan-3β-ol 
suggest a loss of helical structure at 25 molar percent 5α-cholestan-3β-ol. A small 
increase in the amide S mode at 1389 cm-1 is observed in the dUVRR spectrum of 
melittin at 25 molar percent 5α-cholestan-3β-ol (Figure 1-7). This increase in the amide S 
mode indicates a small loss of helical content in the peptide. Concurrently, the amide III 
band at 1240 cm-1 increases. The position of the amide II (1542 cm-1) and amide I (1651 
cm-1) bands are still consistent with those of an α-helical peptide, but with the amide II 
position being slightly downshifted from that observed for soluble helical peptides66-67. 
Although there is a small loss of helical structure, the dUVRR spectra indicate that the 
structure of melittin remains largely intact at the highest molar percentage of 5α-
cholestan-3β-ol, which is further evidenced by the lack of change in the intensity of the 
amide I and amide II modes. 
 
Discussion   	
Melittin is a highly soluble peptide that spontaneously folds in a membrane or 
membrane-mimicking environment. While dUVRR spectroscopy has been employed to 
study the structure and dynamics of a variety of globular proteins, its application to 
membrane proteins has been limited3-4. Of particular note in these previous studies was 
the upshifted and extremely intense amide I mode of membrane proteins versus their 
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soluble counterparts. The dUVRR spectrum of melittin, a much simpler protein, in a lipid 
environment, also has a more intense amide I band versus soluble α-helical proteins. 
However, the position of the amide I band at 1651 cm-1 is consistent with other soluble α-
helical proteins. It can be concluded from the dUVRR spectra of melittin that desolvation 
by bilayer insertion does result in an increase in the intensity of the amide I mode, 
presumably from the loss of hydrogen bonding between water molecules and the 
carbonyl of the amide backbone. However, the upshift and extreme intensity of the amide 
I band in previous studies may derive from additional factors other than the solvation 
environment of the peptide backbone as these were not observed for lipid solvated 
melittin.  
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Figure 1-6: CD (top) and OCD (bottom) spectra of melittin in DMPC liposomes at 37°C 
with 0 molar percent 5α-cholestan-3β-ol (black), 10 molar percent 5α-cholestan-3β-ol 
(grey), and 25 molar percent 5α-cholestan-3β-ol (dashed). 
 
CD spectroscopy has many advantages and is often used for rapid assessment of protein 
structure. However, studies on smaller non-globular proteins show that the CD and 
dUVRR spectra can suggest dramatically different secondary structure distributions44, 54, 
58.  Similar discrepancies were observed between the CD and dUVRR spectra of melittin 
in DMPC liposomes at 37°C and with 5α-cholestan-3β-ol, where a large loss of helical 
structure could be inferred from the CD spectra (Figure 1-3 and Figure 1-6), but the 
dUVRR spectra indicated that the helical structure of melittin remains largely intact. The 
loss of intensity in the CD spectra may be due to a loss of coupling along the axis of the 
helix as the motion of the peptide increases at higher temperatures and becomes more 
elongated at lower fluidities. The ability of 5α-cholestan-3β-ol to disrupt the 
transmembrane orientation of melittin and force the melittin toward a more parallel 
orientation nearer the surface of the membrane could account for the small loss of helical 
structure indicated by dUVRR and the additional loss of CD spectral intensity.  
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Figure 1-7: DUVRR spectra of melittin in DMPC liposomes at 37°C with  
5α-cholestan-3β-ol (molar percentages as indicated). 
 
The temperature profile of melittin shows a decrease in the intensity of the CD spectrum 
with increasing temperature, as was seen previously36. However, the results obtained here 
in lipid vesicles show a much larger change in the CD spectrum over a much narrower 
temperature range than those in bicelles. The large loss in CD intensity is not coupled 
with an increase in the amide S mode of the dUVRR spectra, as would be expected if the 
melittin were losing α-helical character, but rather an increase in the amide III mode. This 
suggests a more fluid membrane environment enables melittin a greater freedom of 
movement resulting in sampling of 310-helical structure but conservation of the peptides 
overall helical structure (Figure 1-8).  
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Figure 1-8: Plot of dUVRR amide III position versus w-angle. 
  
The introduction of 5α-cholestan-3β-ol to the DMPC vesicles at 10 molar percent 
induced little structural change in melittin as indicated by the CD and dUVRR spectra. 
The addition of 25 molar percent 5α-cholestan-3β-ol shows both a dramatic decrease in 
the intensity of the CD spectrum and an increase in the amide S and amide III dUVRR 
modes. These spectral changes indicate a decrease in the α-helical character of melittin 
with increasing 5α-cholestan-3β-ol concentration as is expected from previous studies 
(Figure 1-8)40, 42. The OCD spectra show melittin being mostly transmembrane without 
5α-cholestan-3β-ol. Melittin then becomes less transmembrane with higher 
concentrations of 5α-cholestan-3β-ol. This indicates that the melittin is being forced out 
of the transmembrane orientation by 5α-cholestan-3β-ol. This change in tilt angle for 
melittin could contribute to the loss of α-helical character seen in the CD and dUVRR 
spectra.  
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In conclusion, lipid induced desolvation results in an increase in the intensity of the 
amide I band in the dUVRR spectra of melittin in a membrane bilayer. The amide II, III, 
and S modes appear unaffected by the polarity of the environment of the protein. In 
combination, the amide bands can be used to monitor both a protein’s environment 
(amide I) and secondary structure (amide II, III, and S). In all, by combining CD, OCD 
and dUVRR the subtle structural fluctuations of melittin in changing fluidities were 
elucidated in a way not experimentally achieved previously. 
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Chapter 2 	
Introduction 	
Heart disease is currently the leading cause of death in the United States5. High blood 
cholesterol levels can be an indication of an increased risk of heart disease68-70. 
Cholesterol is naturally produced and metabolized by the liver and transported through 
the bloodstream by particles called lipoproteins6. Lipoproteins are disk- or spherical-
shaped complexes with a hydrophilic exterior made of lipids and proteins that carry 
cholesterol in their hydrophobic core. There are five major classes of lipoproteins that are 
distinguished by the size and density of the particle. The classes, from least dense to most 
dense, are chylomicrons, very low-density lipoproteins (VLDL), intermediate-density 
lipoproteins (IDL), low-density lipoprotein and high-density lipoproteins (HDL). For the 
purposes of this study only VLDL, LDL, and HDL will be discussed. Higher HDL blood 
levels have been linked to a reduction in the risk for heart disease,9-10 as these particles 
can transfer cholesterol that has built up on arterial walls back to the liver where it can be 
broken down and removed from the body. The opposite is true of LDL. Higher LDL 
blood levels increase the chance of heart disease7-8, 11-12 as LDL can promote transport of 
cholesterol to the arterial walls causing the arteries to harden and be restricted.  
The most widely used clinical testing methods for cholesterol, LDL, and HDL do not 
directly measure either LDL or HDL71-72. Instead these tests measure total cholesterol in 
the blood, triacylglycerides and the protein associated with HDL. LDL levels are then 
calculated using the Friedewald73 equation. This manner of lipoprotein testing can yield 
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widely varied results depending on how patients prepare for the test. Considering the link 
between LDL, HDL, and heart disease a more direct approach is needed for lipoprotein 
characterization in blood. 
Deep Ultraviolet Resonance Raman (DUVRR) Spectroscopy is a vibrational technique 
that has been used to monitor both soluble and membrane-associated proteins2, 24, 28, 52, 58, 
66. The utility of dUVRR spectroscopy in protein studies is derived from the resonance 
enhancement of the structurally informative peptide backbone modes over side chain or 
background solvent modes, which can dominate the spectra with traditional Raman 
techniques. This signal enhancement can also be applied to the double-bonded structure 
found in many types of biological molecules like fatty acids, lipids, and cholesterol. The 
ability to simultaneously probe protein, lipid, and cholesterol modes in a sample makes 
dUVRR a unique tool for lipoprotein analysis.     
Materials and Methods 	
Cholesterol, monosodium phosphate monohydrate, disodium phosphate heptahydrate, 
sodium chloride, sucrose, oleic acid, linoleic acid, vaccenic acid, arachidonic acid, 
dithiothreitol (DTT) and chloroform were purchased from Fisher Scientific (Pittsburgh, 
PA). 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) and 1,2-didodecanoyl-
sn-glycero-3-phosphocholine (DLPC) were purchased from Avanti Polar Lipids 
(Alabaster, AL). The Amplex Red Cholesterol Assay Kit was purchased from Thermo 
Fisher Scientific (Waltham, MA). Commercial low-density lipoprotein (LDL) and high-
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density lipoprotein (HDL) were purchased from Feldan (Quebec, Canada). Frozen cow 
brain was purchased from a local supermarket. 
Synaptosome isolation was performed per the method of Hui et. al74 using frozen cow 
brain. The frozen cow brain was homogenized in a 10% sucrose solution and 1 mM DTT 
with a glass homogenizer. The homogenized brain was centrifuged at 700 rcf for 20 
minutes. The pellet was then homogenized in 10% sucrose and centrifuged at 700 rcf for 
20 minutes. The supernatants from the previous centrifugations were combined and 
centrifuged at 10,000 rcf for 30 minutes. The resulting pellet was then re-suspended in 
10% sucrose, layered on 27%/41% sucrose levels, and centrifuged at 100,000 rcf for 2 
hours. The interface of the 27%/41% sucrose layers was collected and centrifuged at 
100,000 rcf for 1 hour. The pellet was then re-suspended in 10% sucrose and the solution 
was centrifuged at 100,000 rcf for 1 hour. The pellet was then incubated in 5 mM Tris-
HCl pH 8.1 for 35 minutes at 0°C and then centrifuged at 100,000 rcf for 30 minutes. 
Synaptosomes were re-suspended in 20 mM phosphate buffer.       
Standard lipid vesicles with cholesterol were formed by first individually dissolving 
DLPC, DOPG, and cholesterol in chloroform. The dissolved lipids/cholesterol were then 
combined to form solutions of 15, 10, and 5 percent cholesterol and 30, 25, and 20 
percent DOPG by weight, with DLPC making up the remaining mass in a glass culture 
tube. The chloroform was then evaporated under a stream of argon to leave a thin film on 
the bottom of the tube. The tubes were further dried overnight in a vacuum desiccator. 
The dried solutions were then rehydrated using a 20 mM phosphate buffer (pH 7.4) and 
sonicated in a bath sonicator until the solutions changed from cloudy to opaque. The 
vesicles formed from this preparation had an average diameter of 25.8 ± 1.5 nm.  
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Whole blood samples were obtained from a local clinical testing laboratory. Blood serum 
was isolated from 10 separate whole blood samples by centrifugation at 10,000 rcf for 10 
minuets75. VLDL, LDL and HDL were separated from each of the 10 samples using a 
gradient of 48% w/w sucrose, and 0.67 M NaCl. The blood serum was adjusted to 4 M 
NaCl then layered on the gradient and centrifuged for 2 hours at 180,000 rcf. VLDL was 
collected from the top of the 0.67 M NaCl layer. LDL was isolated from the interface 
between the 0.67 M NaCl and the 4 M NaCl fractions. HDL was collected from the 
interface of the 4 M NaCl and 48% w/w sucrose fractions.  
Independent cholesterol concentrations were determined using the Amplex Red 
Cholesterol Assay which detects the hydrogen peroxide production of an enzymatic 
reaction with cholesterol76. Fluorescence measurements for the assay were taken on a 
Biotek SynergyMX fluorescence microplate reader. 
The deep ultraviolet resonance Raman (dUVRR) instrument has been described 
previously44. Briefly, the fourth harmonic of a tunable Ti:Sapphire Coherent (Santa Clara, 
CA) laser was focused on a sample flowing between two thin nitinol wires in a nitrogen 
purged sample chamber. The excitation wavelength used was 197 nm with power 
attenuated at the sample to 0.5 mW. Data processing and partial least squares (PLS) 
analysis were done using the MatLab (Natick, MA) environment.  
DUVRR spectra of three sets of standard lipid vesicles were obtained as the calibration 
set for the PLS analysis of LDL isolated from whole blood yielding 27 standard lipid 
vesicle spectra. PLS was performed using the plsregress function in MatLab and the root 
mean square error of calibration (RMSEC) for the prediction of the standard lipid vesicle 
concentrations was calculated.      
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Results 	
 
Figure 2-1. DUVRR spectra (lex = 197 nm) of synaptosomes (left) and commercially 
available HDL and LDL (right).  
 
DUVRR protein spectra contain four discernable amide modes. The amide I (carbonyl 
stretch), amide II (coupled N-H bend/C-H stretch), amide III (Ca-H bend/C-N stretch), 
and in certain protein structures amide S (coupled to the amide III, Ca-H bend/N-H bend, 
not resonantly enhanced in a-helical conformations). These amide modes provide insight 
into protein secondary structure and have proven particularly useful in the analysis of 
lipid-solubilized proteins1-4, 28, 77. Previous studies have shown that the amide I intensity 
is strongly enhanced in the dUVRR spectrum of  a-helical transmembrane proteins3-4.   
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Synaptosomes were isolated to obtain a dUVRR spectrum of a biologically relevant 
membrane system. The dUVRR spectra of synaptosomes (Figure 2-1) reveals a strong 
feature in the amide III region at 1263 cm-1, an amide II band at 1545 cm-1, a weak amide 
S mode at 1383 cm-1, and a very intense feature in the amide I region at 1662 cm-1. The 
position of the amide II band (1545 cm-1) is indicative of a-helical structure, though the 
presence of a weak amide S band (1383 cm-1) is consistent with at least a small amount of 
disordered structure78. Fully disordered proteins typically have an amide III band of 
relatively equal intensity to that of the amide S band78. Thus, the strong feature in the 
amide III region at 1263 cm-1 is more likely the tyrosine ring-O mode79.  
DUVRR spectra of commercially isolated HDL and LDL have intense amide I bands at 
1664 cm-1; however, the intensity of this peak in the LDL spectrum is much greater than 
that in the HDL spectrum suggesting the intensity derives from a source other than 
transmembrane a-helices. The aromatic modes at 1211 cm-1, 1261 cm-1, and 1605 cm-1 
are less intense in the LDL dUVRR spectrum, likely indicating a higher protein content 
within the HDL particles.  
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Figure 2-2. DUVRR spectra of fatty acids (left), the unsaturated lipid, DOPG (right, 
black), and cholesterol (right, gray). 
Many biological membrane components like fatty acids, unsaturated lipids, and 
cholesterol contain C-C double-bonded structures. Previous studies have shown that 
saturated lipids do not exhibit a strong dUVRR feature in this region2, 28. DUVRR spectra 
of isolated fatty acids, the unsaturated lipid DOPG, and cholesterol have intense features 
in the 1655-1670 cm-1 region (Figure 2-2).  
Both cis (arachidonic acid, linoleic acid, and oleic acid) and trans (vaccenic acid) fatty 
acids were evaluated for this study. All cis fatty acid dUVRR spectra contained one main 
spectral feature at 1661 cm-1, which was slightly red shifted in dUVRR spectrum of the 
trans fatty acid to 1655 cm-1. Both vaccenic acid and oleic acid contain a single double 
bond, but the intensity of the dUVRR spectrum for the trans vaccenic acid is less than 
that of the cis oleic acid. The intensity of the dUVRR special feature at 1661 cm-1 for the 
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cis fatty acids also increases with increasing number of double bonds. Oleic acid has a 
single double bond and is the least intense, linoleic contains two double bonds and is 
second most intense, and arachidonic acid has four double bonds and is the most intense. 
Cholesterol and lipids are major components in animal cell membranes. DOPG was 
chosen as a representative unsaturated lipid species and was analyzed in conjunction with 
cholesterol. DOPG contains two cis C-C double bonds with a main dUVRR spectral 
feature at 1660 cm-1. Cholesterol has a single double bond but it is contained on the 
inside of a ring structure. The dUVRR feature for cholesterol can be seen at 1668 cm-1. 
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Figure 2-3. Representative DUVRR spectra of VLDL (top), LDL (middle), and HDL 
(bottom) and the underlying lipid (lipid peak) and cholesterol (cholesterol peak) 
components.    
 
The three major features in the dUVRR spectra of VLDL, LDL, and HDL separated from 
blood serum (Figure 2-3) are the tyrosine/amide III feature (1265 cm-1), a lipid feature 
	31 
around 1660 cm-1, and a cholesterol feature around 1675 cm-1. The tyrosine/amide III 
band is used as an indicator of protein content in the lipoprotein particles.    
  
 
Figure 2-4. Correlation plots for the ten VLDL (left), LDL (center), and HDL (right) 
samples of the integrated tyrosine/amide III peak area versus Amplex Red cholesterol 
assay concentration (top) and the integrated cholesterol peak area versus Amplex Red 
cholesterol assay concentration (bottom). 
 
 
The dUVRR tyrosine/amide III peak area increases with increasing cholesterol 
concentration, as measured by the Amplex Red cholesterol assay (Figure 2-4, top). These 
data suggest that the measured cholesterol concentration is correlated with the total 
amount of lipoprotein present in the blood serum samples. Comparison of the peak area 
of the fitted band at ~1675 cm-1 versus the measured cholesterol concentration shows that 
there is no linear relationship between the total cholesterol content and the 1670 cm-1 
peak intensity excepting the VLDL samples (Figure 2-4, bottom). For the HDL samples, 
it is likely that the intensity of the amide I band interferes with estimation of the 
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cholesterol peak intensity. However, the dUVRR spectra of LDL samples were largely 
devoid of protein bands suggesting that the lack of correlation may not be solely an 
interference issue. It is possible that dUVRR is sensitive to individual variations in the 
amount of cholesterol with the lipoproteins themselves. For example, a sample that is low 
in total LDL will have a lower measured cholesterol value via the Amplex Red assay but 
could have a higher percentage of cholesterol within the LDL that is present in the 
sample.  
 
 
 
 
Figure 2-5. Representative dUVRR spectra of the standard lipid vesicles (left) and a table 
representing the standard vesicle compositions (right). Each of the nine concentration 
levels was prepared in triplicate for a total of 27 standard lipid vesicles. DUVRR spectra 
are colored by cholesterol content: 6 mM (black), 4 mM (dark gray), 2 mM (light gray). 
 
Standard lipid/cholesterol vesicles were made from saturated lipid (DLPC), unsaturated 
lipid (DOPG), and cholesterol. The dUVRR spectra of the standard lipid/cholesterol 
Cholesterol DOPG DLPC 
6mM (15 %) 30% 55% 
6mM (15 %) 20% 65% 
6mM (15 %) 25% 60% 
4mM (10%) 30% 60% 
4mM (10%) 20% 70% 
4mM (10%) 25% 65% 
2mM (5%) 30% 65% 
2mM (5%) 20% 75% 
2mM (5%) 25% 70% 
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vesicles have a unsaturated lipid feature at 1661 cm-1 and a cholesterol feature at 1675 
cm-1 (Figure 2-5), that are dependent on the percentage of cholesterol. As the cholesterol 
content increases, the raw intensity of the unsaturated lipid peak decreases, shifting the 
ratio of the two peaks. This effect may be due to increased self-absorption of the Raman 
scattering as the content of cholesterol increases.  
Normalization of this feature to unit length in both the standard lipid/cholesterol vesicles 
and the LDL samples corrects for any intensity differences between the two data sets and 
puts them on the same scale. The standard lipid/cholesterol vesicles can then be used to 
create a calibration curve to predict the percent cholesterol present in LDL samples using 
PLS (Figure 2-6). 
 
Figure 2-6. Plot of the cholesterol concentration and predicted cholesterol concentration 
for the nine samples of replicate 1 (black squares), nine samples of replicate 2 (dark grey 
triangles), and nine samples of replicate 3 (light grey circles) each of the standard lipid 
vesicles using PLS.  
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Figure 2-7. Predicted cholesterol concentration for LDL based on PLS results using 
standard lipid vesicles (left), dUVRR spectra of LDL sample three (grey) and sample 4 
(black) normalized to unit area (center, top), raw dUVRR spectra of LDL sample three 
(grey) and sample 4 (black) (center, bottom), and cholesterol assay concentrations for the 
ten LDL samples.   
 
The PLS model was applied to the LDL samples only as they are the closest match in 
composition to the standard lipid/cholesterol vesicles. The HDL samples have a much 
higher protein content and will therefore have the largest underlying amide I protein 
contribution in the 1661 cm-1 and 1675 cm-1 region of the dUVRR spectrum, which 
would make cholesterol determination with a model devoid of protein difficult. Further 
studies are needed to identify a suitable standard model for direct quantification of 
cholesterol in HDL. VLDL, has very little cholesterol. Consequently, the dUVRR spectra 
of the VLDL samples have a strong feature, mostly derived from the unsaturated lipid 
feature, at 1675 cm-1. PLS of the LDL samples returns a narrow concentration range 
between 13.3% and 15.6% by weight cholesterol (Figure 2-7, left). When the normalized 
dUVRR spectra used for the PLS analysis of the highest and lowest predicted cholesterol 
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concentration samples (Figure 2-7, top, center) are compared, a difference in the ratio 
between the lipid peak and the cholesterol peak is seen. In Sample 3, the lipid peak has a 
lower intensity than that of the cholesterol peak leading to a higher predicted cholesterol 
concentration. In Sample 4 the opposite is true. The cholesterol peak is much lower than 
the lipid peak and leads to the lower predicted cholesterol concentration for that sample.  
When compared to the cholesterol concentration determined by the Amplex Red Assay 
(Figure 2-7, right) we see that Sample 3 has a much lower cholesterol concentration than 
that of Sample 4. The raw dUVRR spectra of the two samples shows a less intense 
spectrum for Sample 3 when compared with Sample 4. Taken together with the results of 
the PLS analysis on the same two samples, an interesting trend emerges. The Amplex 
Red cholesterol assay reports on total cholesterol in solution and is consequently 
reporting on the total amount of lipoprotein in solution. This total amount of lipoprotein 
in solution is also being reported by the raw dUVRR spectrum by the intensity of the 
combined lipid/cholesterol peaks. Further analysis of the dUVRR spectrum reveals that 
the ratio between the lipid and cholesterol peaks is reporting on the amount of cholesterol 
contained within the lipoprotein particles themselves. Thus, dUVRR can simultaneously 
report on both the global amount of lipoprotein in solution and yield insights on the 
composition of the lipoproteins.         
Discussion 	
DUVRR spectra of biological molecules (Figures 2-1 and 2-2) reveal a new utility for the 
technique. The double bond contained within these molecules shows a large resonance 
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enhancement allowing them to be easily detected at low relative concentrations. DUVRR 
not only allows for the detection of these molecules but can even discern between the 
type of double bond in the biomolecule. The trans double bond found in vaccenic acid 
(Figure 2-2), the cis double bond in the lipid DOPG, and the ring double bond of 
cholesterol all occur at different frequencies in dUVRR spectra. The sensitivity and 
selectivity of the double-bond character of these lipid molecules will allow dUVRR to be 
used in complex systems. Combined with multivariate analysis or fitting, spectral 
features have the potential to increase the utility of dUVRR in the analysis of lipids and 
lipid soluble compounds. 
Lipoprotein analysis by dUVRR yields a wealth of information as the technique can 
simultaneously observe the protein, lipid, and cholesterol contained within the lipoprotein 
molecules. DUVRR and Amplex Red cholesterol assay analysis of a set of 10 VLDL, 
LDL, and HDL samples separated from blood serum reveals that dUVRR can not only 
report on total cholesterol but the percent composition of cholesterol within each 
lipoprotein particle as well. The Amplex Red cholesterol assay measures total cholesterol 
in solution by a series of enzymatic reactions. The actual analyte of the process is not 
cholesterol but a hydrogen peroxide product of one of the enzymatic reactions. The 
Amplex Red assay has no ability to distinguish between a sample with a few lipoprotein 
particles containing a high percentage of cholesterol and many lipoprotein particles with 
a low percentage of cholesterol.  
DUVRR spectroscopy of lipoproteins has the potential to be useful in the simultaneous 
monitoring of both total lipoprotein concentration in solution and the percentage of 
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cholesterol contained within those lipoproteins. The dUVRR tyrosine/amide III band is a 
good monitor of protein content and scales with the Amplex Red cholesterol assay total 
cholesterol determination. The percentage of cholesterol within the lipoprotein molecules 
may be determined using a set of standard calibration samples and PLS regression, 
though other multivariate calibration methods may perform equally well. Combination of 
multivariate regression and dUVRR spectral analysis yields reasonable estimates of the 
percentage of cholesterol within the lipoprotein molecules. More research on the 
importance of cholesterol content within lipoproteins is needed. Additionally, dUVRR 
may be an effective detection method for in-line separation and measurement of 
lipoprotein content and size distributions, which have been shown to have relevance to 
cardiovascular disease80-81.  
While one of the most traditional applications of dUVRR spectroscopy has been in the 
field of protein secondary structure determination, a new utility of dUVRR to study lipids 
and cholesterol opens the door to a host of new applications for the technique. 
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Chapter 3 
 
Introduction 	
Heart disease is currently the leading killer in the United States today and affects over a 
third of the population5. There are many risk factors for heart disease but one of the most 
talked about is the link to blood cholesterol levels68-70. Cholesterol itself is not soluble in 
the blood stream as it is too hydrophobic. Instead cholesterol is encapsulated and 
transported through the body by molecules known as lipoproteins. Lipoproteins have a 
hydrophobic core made of lipids that hold cholesterol; the hydrophobic core is wrapped 
in proteins that help solubilize the lipoproteins in the blood stream. Lipoproteins are 
usually disk or spherically shaped and are defined by their densities. There are five major 
categories of lipoproteins which include chylomicrons, very low density lipoprotein 
(VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL), and high 
density lipoprotein (HDL). As protein content increases, lipoproteins become smaller and 
denser. Chylomicrons have virtually no protein, the largest radius and are the least dense. 
HDL has the largest protein content, the smallest radius and is the densest type of 
lipoprotein. As in the previous chapter of this work only VLDL, LDL, and HDL were 
included in the analysis. 
In the clinical setting total blood cholesterol, LDL, and HDL levels are what is most 
commonly measured. Increased levels of LDL have been linked to an increased risk of 
heart disease7, 11-12, whereas increased HDL levels have been linked to a decreased risk 
for heart disease9-10. The most common methods used in the clinic do not measure LDL 
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or HDL levels directly71-72. Instead whole blood cholesterol, triglycerides, and the protein 
associated with HDL is measured. LDL levels are then calculated using the Friedewald 
equation. More direct methods for measuring blood HDL and LDL levels such as nuclear 
magnetic resonance82-85. ultracentrifugation86-89, and electrophoresis90-93 exist but require 
more time, money, or data analysis than the current clinical methods.  
While lipoproteins are characterized by their densities, a wide distribution of sizes exists 
within the particle categories. This size distribution allows for the use of size exclusion 
chromatography to help separate lipoprotein species from one another in a blood serum 
sample. Size exclusion chromatography (SEC) is a separation technique that works by 
passing particles through a stationary phase with a certain pore size94-95. If the particles 
are smaller than the pore size they can enter the matrix of the stationary phase and will be 
retained on the column. If they are larger than the matrix they will be excluded and elute 
off the column. Ideally, with a size based separation there will be no interaction between 
the stationary phase and the analytes as there is in most other separation techniques. 
Instead the analytes will be separated by the differences in size alone. There are several 
advantages to using SEC in the analysis of lipoproteins. The major advantage is that very 
little sample prep is required. Blood samples can be collected, the serum or plasma 
isolated, and placed directly into the chromatography system. 
Deep Ultraviolet Resonance Raman (dUVRR) Spectroscopy is a vibrational technique 
that has been used previously in the determination of secondary structure for both soluble 
and membrane-associated proteins2, 77, 96-97. Resonance enhancement of the peptide 
backbone vibrational modes provides rapid structural insights with little sample 
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preparation. DUVRR is also sensitive to the carbon-carbon double bonds found in 
biological molecules like fatty acids, unsaturated lipids, and cholesterol. Resonant 
enhancement of this characteristic double bond allows for a new method of cholesterol 
quantitation.  
There have been many studies that employ multivariate calibration and higher order 
statical techniques to the dUVRR analysis of proteins27, 78, 98-99. Analyses like multivariate 
curve resolution-alternating least squares (MCR-ALS) and parallel factor analysis 
(PARAFAC) can analyze complex data sets and reveal underlying spectral and 
chromatographic components when the composition of the analyte is not known.   
Here we present a new multifaceted approach for measurement of lipoprotein profiles by 
combing SEC, dUVRR, and multivariate analysis. The vast range in lipoprotein size 
allows for good separation of the lipoprotein types by SEC. These SEC fractions can then 
in turn be analyzed by dUVRR for identification and cholesterol content. Finally, the 
dUVRR data can be processed using multivariate calibration techniques. This workflow 
allows for a single continuous analysis that yields not only a lipoprotein profile, but 
potentially critical information about the composition of each lipoprotein fraction.  
Materials and Methods 	
Monosodium phosphate monohydrate, disodium phosphate heptahydrate, and sodium 
sulfate were purchased from Fisher Scientific (Pittsburgh, PA). Blood collection tubes 
and needles were purchased from Becton, Dickenson, and Company (Franklin Lakes, 
NJ).   
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Five blood serum samples were isolated from whole blood, donated by graduate students, 
by centrifugation at 10,000 rcf for 10 minutes. The serum was then separated using fast 
protein liquid chromatography (FPLC) on a Bio-Rad system using a GE (Pittsburg, PA) 
Superose 6 size exclusion column (5-5000 kDa separation range for globular proteins). A 
mobile phase of 20 mM phosphate and 250 mM sodium sulfate, injection volume of 500 
µL, and a flow rate of 0.5 ml/min were used. Fractions of 1 mL were collected for the 
entirety of the FPLC run for each sample.  
Independent cholesterol concentrations were determined using the Amplex Red 
Cholesterol Assay which detects the hydrogen peroxide production of an enzymatic 
reaction with cholesterol76. Fluorescence measurements for the assay were taken on a 
fluorescence microplate spectrometer. 
The deep ultraviolet resonance Raman (dUVRR) setup has been described previously44. 
Briefly, the fourth harmonic of a tunable Ti:Sapphire Coherent (Santa Clara, CA) laser 
was focused on a sample flowing between two thin nitinol wires in a nitrogen purged 
sample chamber. The excitation wavelength used was 197 nm with power attenuated at 
the sample to 0.5 mW. All data processing and analysis were carried out in Matlab 
(Mathworks, Natick, MA).  
Parallel factor analysis is typically used to deconstruct a multi-way data array to aid in 
identification and quantification of underlying components in samples with unknown 
concentrations100-104. The PARAFAC analysis done here is based on a trilinear model100 
as shown in equation 1.  
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𝑟+,- = 𝑥+,0𝑦,,0𝑧-,0 + 𝑒+,,,-4056 														(1) 
The trilinear data set for this work was created by combining dUVRR spectra of 17 SEC 
fractions from 5 different blood serum samples creating a rijk from equation 1 measuring 
the ith wavenumber of the jth SEC fraction from the kth blood serum sample. The 
PARAFAC algorithm has been described previously105. A core consistency diagnostic106 
was used to determine the PARAFAC model parameters. This type of diagnostic on a 
similar data set has been described previously99. A three-factor model with non-negativity 
restraints was chosen because this model yielded the best core consistency (34.3%). The 
addition of a third factor results in a drop in the core consistency from 100% with two-
factors but was greater than that of a three-factor model without non-negativity restraints 
(24.4%), and much greater than a four-factor model (2.4%) and a four-factor model with 
non-negativity constraints (3.8%).  
MCR-ALS analysis was done on the same data set as the PARAFAC analysis using an 
algorithm originally developed by Bro and Sidiropoulos107. The MCR-ALS analysis was 
initialized using the outputs of an evolving factor analysis and was also constrained to 
nonnegative values. MCR-ALS will resolve a concentration set and pure spectral values 
from the original data matrix. The concentration set will be comprised of the amount of 
the underlying factors from the data set.  
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Results  	
 
Figure 3-1. Size exclusion chromatograms (SEC) for five blood serum samples.   
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Figure 3-2. Representative set of dUVRR spectra from the fractions collected during a 
SEC analysis of blood serum.  
 
Chromatographic analysis of lipoproteins 
Lipoproteins are a composite of lipids, cholesterol and proteins. Tryptophan, which 
absorbs strongly at 280 nm is a major component of proteins. Thus, monitoring the 
absorption at 280 nm will enable detection of any component with a significant amount 
of protein associated with it. The size exclusion chromatograms of blood serum samples 
with UV detection at 280 nm are very similar and have several interesting features. 
(Figure 3-1).  
The first chromatographic feature occurs from 8-10 mL and represents the largest 
particles in the blood serum samples. These large particles have been completely 
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excluded from the matrix of the SEC column. This early chromatographic band is likely a 
combination of chylomicrons and VLDL. The relatively low intensity of the absorption at 
280 nm can be attributed to the small amount of protein in these particles. From 12-15 
mL, a small shoulder appears on the larger band at 15-19 mL. These two 
chromatographic components represent biomolecules with lower and higher protein 
absorption, possibly LDL and HDL, respectively.  The last chromatographic feature from 
19-21 mL is close to the total volume of the column and represents smaller compounds, 
potentially free protein.  
The ability to conduct qualitative analysis of chromatographic data with single 
wavelength absorption detection is limited. A series of dUVRR spectra were collected 
from sequential fractions of five SEC separations of blood serum. Typical protein 
dUVRR spectra contain four distinct amide modes. These amide modes consist of a 
carbonyl stretch (amide I), a coupled N-H bend/C-H stretch (amide II), a Ca-H bend/C-N 
stretch (amide III), and in certain proteins structures a Ca-H bend/C-N bend (amide S) 
that is coupled to the amide III but is not resonantly enhanced in a-helical 
conformations24-25, 55, 108-109. The amide modes of the dUVRR spectra report on the 
secondary structure of proteins and have been utilized effectively to study lipid-
solubilized proteins,1-4, 28, 77 with a particularly strongly enhanced amide I mode in 
transmembrane a-helices3-4. There are also three main spectral regions of interest when 
studying lipoproteins by dUVRR as seen in Chapter 2 of this work. First is the 
tyrosine/amide III feature at 1265 cm-1 which reports on protein content in the lipoprotein 
particles. The second and third regions are an overlapped lipid band (1660 cm-1) and 
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cholesterol band (1675 cm-1). These bands simultaneously carry information on the 
amount of lipoprotein in solution, which correlated with the magnitude of the combined 
lipid and cholesterol peak, and the amount of cholesterol within the lipoprotein particle 
itself, which is related the intensity ratio between the lipid peak and the cholesterol peak.  
SEC-dUVRR spectra have characteristic features that can be attributed to the sulfate ion 
at 978 cm-1 and the broad water band at 1640 cm-1 in nearly pure buffer at 8 mL (Figure 
3-2). After the 8 mL fraction, there is a rapid rise in the lipid/cholesterol feature at 1660 
cm-1 through the 10 mL fraction, correlating with the earliest feature in the size exclusion 
chromatograms. As the intensity of the lipid/cholesterol band drops, the amide 
III/tyrosine feature at 1265 cm-1 increases in intensity, indicating particles with higher 
combined protein and cholesterol contents.  Towards the end of the separation, the 
lipid/cholesterol feature disappears while the protein modes remains, indicating free 
protein is being eluted from the column.   
 
Figure 3-3. PARAFAC analysis of SEC-dUVRR samples with non-negativity restraints. 
The three components from the PARAFAC analysis are buffer (light grey), 
lipid/cholesterol (dark grey), and protein (black). The predicted spectral results (left), 
amount of component per SEC fraction (middle), and amount of each factor per sample 
(right) are shown.    
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Multivariate analysis of SEC-dUVRR spectra of blood serum 
Combined chromatographic and spectral analysis of several blood serum samples results 
in a trilinear data array that can be rapidly analyzed using multi-way methods such as 
PARAFAC. A three-factor PARAFAC model with non-negativity constraints was 
determined to be the optimal model. Three-factors were resolved that correspond 
spectroscopically to a buffer component (light grey), a protein component (black), and a 
lipid/cholesterol component (dark grey) (Figure 3-3, left).  
Evaluation of the SEC profiles, indicates that the buffer component is dominant initially 
and drops through the 22 mL fraction, at which time it increases again (Figure 3-3, 
middle). Conversely, the protein component is absent initially and increases slowly 
through the 22 mL fraction, where the protein component begins to taper off. 
Interestingly, the protein component increases from the 10-12 mL fractions and then 
levels off between the 12-14 mL fractions and then increases again through the 16 mL 
fraction suggesting multiple underlying chromatographic components. There are two 
maxima in the chromatographic profile of the lipid/cholesterol component. The first peak 
occurs at the 10 mL fraction, after which the intensity falls sharply, with an asymmetrical 
shoulder centered around the 14 mL fraction. Comparison of the relative amounts of each 
resolved component in the serum samples indicates that samples 1 and 3 are more similar 
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with a greater lipid/cholesterol to protein ratio, whereas samples 2, 4 and 5 have greater 
protein to lipid/cholesterol ratios (Figure 3-3, right).  
There is insufficient resolution in the separation to enable clear differentiation of the 
lipoprotein particles. However, PARAFAC analysis resolves three distinct spectral and 
chromatographic features that can be used to differentiate the lipoproteins in the fractions 
based on their relative proportion of the lipid/cholesterol and protein features. Given that 
each individual’s amount and size distribution of lipoproteins is different, the 
chromatographic profiles may not be identical for all samples. In such a case, the 
trilinearity constraint is not entirely fulfilled. 
 
Figure 3-4. Resolved dUVRR spectral components for the MRC-ALS analysis of the 
SEC fractions. 
 
	49 
If it is assumed that the underlying spectral profiles are the same for each sample, but the 
chromatographic profiles may vary, MCR-ALS can be used to resolve the global spectral 
and individual chromatographic profiles. The resolved dUVRR spectra from the MCR-
ALS analysis with non-negativity constraints of the data set (Figure 3-4) is similar to 
those estimated using the PARAFAC model. Again, there is a buffer component (light 
grey), a protein component (black), and a lipid/cholesterol component (dark grey).   
 
Figure 3-5. Plot of intensity of the three resolved MCR-ALS factors versus SEC fraction 
for the MCR-ALS analysis of the dUVRR spectra of SEC fractions. The three factors are 
lipid/cholesterol (left), protein (middle), and buffer (right). 
 
The individual resolved chromatographic profiles from MCR-ALS are again similar to 
the global chromatographic profiles estimated with PARAFAC analysis, except that 
sample-to-sample differences become apparent.  The lipid/cholesterol and protein profiles 
are less intense for sample 3 (Figure 3-5, left and middle, respectively), whereas the 
buffer profile (Figure 3-5, right) is more intense suggesting a lower overall level of 
lipoproteins.  The largest difference in the lipid/cholesterol chromatographic profiles 
(Figure 3-5, left) is at 11 mL, where chylomicrons and VLDL particles are eluting. The 
	50 
greatest sample variance is in the protein chromatographic profiles, especially between 
volume fractions 12-14 mL and 15 to 20 mL (Figure 3-5, middle).  
 
Discussion 	
SEC separation of blood serum enables separation of various sized lipoprotein particles 
including chylomicrons/VLDL, LDL and HDL. SEC combined with dUVRR provides 
insight into the complex distribution of an individual’s lipoproteins. Both PARAFAC and 
MCR-ALS analysis resolved a lipid/cholesterol, protein and buffer spectral profiles. 
MCR-ALS, enabled evaluation of individual chromatographic profiles. Inclusion of more 
samples combined with selective analysis of the lipid/cholesterol region may enable 
resolution of the lipid and cholesterol features in the future. 
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Conclusion 	
Here the utility of dUVRR as both a powerful tool for analysis of not only membrane 
protein structure and solvation state but also as a new means for cholesterol analysis is 
demonstrated. DUVRR was able to distinguish between melittin losing α-helical structure 
with an increase in cholesterol in the membrane system and melittin gaining more 
freedom in a more fluid lipid environment with increasing temperature, a change that 
could not be distinguished in the CD.  
A unique resonance enhancement of the carbon-carbon double bound found in 
biomolecules like fatty acids, unsaturated lipids, and cholesterol with resolvable 
frequency shifts between cis, trans, and internal ring carbon-carbon double bonds has 
been discovered. The intensity of this new feature also scales with increasing number of 
double bonds and concentration allowing dUVRR to be applied to the field of cholesterol 
quantitation. When comparing LDL particles to standard unsaturated lipid/cholesterol 
containing vesicles it was found that the intensity of the lipid/cholesterol feature scales 
with the total amount of lipoprotein in solution, while the ratio between the lipid and 
cholesterol features within the dUVRR spectra is correlated to the amount of cholesterol 
contained within the lipoprotein particles themselves.  
When paired with SEC and multivariate analysis methods dUVRR could distinguish 
between lipoprotein types in the separation chromatogram and determine lipoprotein 
particle and cholesterol concentrations within those particles as previously discussed. 
Overall, dUVRR has been shown to be a powerful technique with applications in not only 
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the traditional field of protein structural analysis but also in the field of lipoprotein and 
cholesterol analysis. 
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